Barely Significant
← all excerpts

Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients.

Br J Cancer · 2004 · PMC2409621 · PMID 14997191

Europe PMCDOI
2
hedged sentences
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP <0.0001actually significant
This difference was highly significant ( P <0.0001).

also in 83,176 other papers

marginally statistically significantno p-value reported
However, a marginally statistically significant survival advantage from neoadjuvant chemotherapy was noted for younger patients, whereas the reverse may be true for older patients.

also in 639 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.